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Abstract Alcohol use can limit the effectiveness of
antiretroviral therapy (ART) for people living with HIV
(PLH) who have a history of injecting drug use. This study
described the patterns of alcohol use among PLH with a
history of injecting drug use in Vietnam and examined the
relationships between alcohol use, adherence to ART, and
sexual risks. We utilized cross-sectional data of 109 PLH
on ART collected from a randomized controlled interven-
tion trial in Vietnam. Approximately 30 and 46% of the
participants were frequent and occasional drinkers,
respectively. Frequent drinkers reported the highest num-
ber of missed medication days. About 61% of frequent
drinkers reported having sex after using alcohol. Addi-
tionally, 23, 34, and 24% of nondrinkers, occasional
drinkers, and frequent drinkers, respectively, reported
inconsistent condom use during sex. Future intervention
programs should address the issues of alcohol use and
sexual risks to maximize the effectiveness of HIV treat-
ment programs in Vietnam.
Keywords Alcohol · HIV · Treatment adherence · Sexual
behavior · Vietnam
Introduction
Alcohol use has been widely recognized as a significant
contributor to illness and injury, accounting for a sub-
stantial proportion of the global burden of disease [1, 2].
People living with HIV (PLH) often report high levels of
alcohol consumption and alcohol use disorders [3, 4].
However, previous studies have shown that alcohol use
might present a unique risk to PLH and could result in
faster disease progression, higher potentiation of comorbid
conditions, and increased HIV-related morbidity and
mortality [5–8]. Furthermore, alcohol use can influence
HIV viral replication, exacerbate immunosuppression, and
induce liver fibrosis [9–11]. Additionally, compared with
HIV-negative individuals, PLH may be more susceptible to
alcohol-related harms such as alcohol intoxication, alcohol-
related death, and physiological injury, even with a low
level of alcohol use [3, 9].
Alcohol use has been considered a prominent risk factor
in the transmission of HIV, as it can impair individual’s
sexual decision making, reduce the use of a condom, and
weaken immune systems [12, 13]. A prior study reported
that drinkers had a 57% greater chance of being HIV
positive compared to nondrinkers [14]. Alcohol use among
people with a history of injecting drug use has been asso-
ciated with sexual risk behaviors, including using condoms
inconsistently and having multiple sex partners [15, 16].
Similarly, alcohol use was found to be associated with
unprotected sex among PLH [17, 18]. For PLH who have a
history of injecting drug use, alcohol use may also increase
needle-sharing behaviors [19]; however, studies on this
topic have reported conflicting results [20–22]. A meta-
analysis found that alcohol use before or during discrete
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In addition to the risks that alcohol itself poses to PLH,
those who drink alcohol experience frequent interruptions
to antiretroviral therapy (ART), an increased occurrence of
adverse medical events due to ART, and an impaired
response to treatment [9, 24, 25]. Specifically, alcohol use
has been shown to be a strong risk factor for poor ART
adherence, with estimated odds ratios ranging from 1.7 to
4.7 [9, 26–28]. The need to maintain a high level of
adherence to ART has remained a challenge to achieve
maximal treatment benefits [29, 30]. The fear of mixing
alcohol with ART which could result in antiretroviral
toxicity can lead to treatment interruptions in PLH [31].
The relationship between alcohol use and ART has
attracted increased attention in recent years [32]; however,
the findings related to the effects of alcohol consumption
on ART outcomes have been mixed. Several studies have
shown that alcohol consumption does not affect HIV
treatment or survival outcomes, including CD4 count and
viral suppression [33–35].
There are approximately 256,000 PLH in Vietnam,
where the epidemic has been largely driven by injecting
drug use [36]. Vietnam is among the few countries in the
world with the highest increasing rates of alcohol con-
sumption [37]. By the end of 2013, ART coverage in
Vietnam had reached 68%, with a 12-month treatment
retention rate of 85% [36]. PLH with a history of injecting
drug use have been found to be more likely to be heavy
drinkers [38, 39], to have a lower uptake of ART, and to
engage in more sexual risk behaviors than the general
population [22, 40]. Therefore, there is an urgent need to
examine the associations between alcohol use, HIV treat-
ment adherence, and sexual risk in this population. The
objective of this study was to describe the patterns of
alcohol use and examine the associations of alcohol use
with ART adherence and sexual risk among PLH in Viet-
nam who have a history of injecting drug use and are
currently on ART.
Method
Study Design and Participant Recruitment
This study used baseline data from a randomized controlled
intervention trial for people with a history of injecting drug
use in Vietnam. The trial was conducted in two provinces,
Vı˜nh Phu´c and Phu´ Tho
˙
, in northern Vietnam. The baseline
assessment was conducted from October 2014 to February
2015. There were 60 communes selected from the two
provinces. We recruited study participants at the commune
health centers where individuals with a history of injecting
drug use typically seek health services [41]. Health care
providers at the centers verbally introduced the project to
potential participants and showed them a printed flyer.
Trained recruiters met individually with prospective par-
ticipants to screen them for eligibility. The inclusion
criteria of the intervention trial were as follows: (1) being
at least 18 years old; (2) reporting a history of injecting
drug use; (3) being a resident of one of the selected com-
munes; (4) providing informed consent. At baseline, 900
people with a history of drug use were recruited, 146 of
whom were HIV positive and 109 were receiving ART at
the time of the study. Thus, 109 PLH on ART were
included in this study. The study obtained ethical approval
from the participating institutional review boards (IRBs) in
the United States and Vietnam.
Data Collection
After providing informed consent, the participants com-
pleted the assessment individually using Audio Computer-
Assisted Self-Interview (ACASI), which allowed the par-
ticipants to listen to prerecorded survey questions through
headphones and privately answer sensitive personal ques-
tions on a computer using a keypad. An interviewer was
available to provide clarifications of the survey questions
and assistance with ACASI. We conducted the assessment
in a private room at the local health centers. Each assess-
ment took approximately 45 min, and each participant
received 80,000 đo`ˆng (4 U.S. dollars) for their participa-
tion. The refusal rate of participation was less than 5%.
Measures
Alcohol Use
The participants were asked currently how often they drink
alcohol, including beer, red wine, white wine, and other
alcoholic beverages. The responses were divided into six
categories (1 = almost daily; 2 = 3–4 times a week; 3 = 1–
2 times a week; 4 = 1–2 times a month; 5 = no more than
once a month; 6 = never). For the analyses, the alcohol use
patterns were categorized into three groups (0 = non-
drinker; 1 = occasional drinker; 2 = frequent drinker).
Participants were defined as “nondrinkers” if they reported
never drinking alcohol, “occasional drinkers” if they
reported using alcohol no more than once or 1–2 times a
month, and “frequent drinkers” if they consumed alcohol
1–4 times a week or almost daily.
ART Adherence
The participants were asked how long they had been
receiving ART and the number of times that they had
missed taking their ART medication in the past 30 days.
Additionally, we used the Antiretroviral General
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Adherence Scale (AGAS) to describe how people felt about
and adhered to their ART regimen in the past 30 days [42].
The participants were asked to rate the frequency with
which they experienced each of the five items on a 5-point
scale (1 = none of the time; 2 = a little of the time;
3 = some of the time; 4 = most of the time; 5 = all of the
time). Four items from the original 5-item scale were
included in the current study based on internal consistency,
including “I found it easy to take my ART medications as
my health care provider advised” and “I took my medicines
exactly as my health care providers advised”. Scores on the
four items were summed to create an overall measure of
general ART adherence that ranged from 4 to 20, with a
higher score reflecting better adherence. The internal con-
sistency (Cronbach’s alpha) of the adapted AGAS in this
sample was 0.92.
Sexual Risk
Sexual risk was assessed via two categorical indicators: sex
after alcohol use and condom use in the past 6 months. The
participants were asked to report whether they had had sex
after using alcohol (0 = no; 1 = yes). They also reported
on their use of condoms during sex in the past six months
with different types of partners: (1) regular, (2) casual, and
(3) commercial sex partners. Participants who reported that
they had not used condoms with any type of sexual partners
were considered to have inconsistent condom use, whereas
participants who reported that they had not had sex or had
always used condoms with all sexual partners were cate-
gorized as having consistent condom use/no sex.
Demographic and background characteristics were also
collected, including gender, age, education, marital status,
annual family income, and year of HIV diagnosis.
Data Analysis
First, the distributions of demographic and background
variables were described for all 109 participants and by
patterns of alcohol use. Second, self-reported days of
missing ART and adapted AGAS scores were calculated
according to patterns of alcohol use. Third, the sexual risk
indicators, including sex after alcohol use and consistent
condom use, were summarized by patterns of alcohol use.
Finally, Fisher’s exact test and analysis of variance
(ANOVA) were performed to determine whether there
were significant differences in the variables above between
participants with different patterns of alcohol use. The
statistical analyses were conducted using SAS software
version 9.4 (Cary, NC).
Results
The demographic and background characteristics of the
sample by patterns of alcohol use are summarized in
Table 1. The mean age of all 109 participants was
39.4 years, with more than half (n = 61; 56.0%) of them
aged between 36 and 45 years old. Males accounted for the
majority of the sample (n = 98; 89.9%). Approximately
half (n = 57; 52.3%) of the participants reported 10 or
more years of education, and the majority (n = 79; 72.5%)
were married or living with a partner. The average annual
family income was approximately 2103 U.S. dollars, with
nearly a fifth (n = 21; 19.3%) of the participants reporting
household incomes less than 1000 U.S. dollars. About forty
percent of the sample (n = 44; 42.7%) were diagnosed with
HIV between 2006 and 2010. The average duration of ART
was 4.5 years, with 39.8% (n = 43) of the participants
having received more than five years of treatment. Non-
drinkers, occasional drinkers, and frequent drinkers
accounted for 23.9% (n = 26), 45.8% (n = 50), and 30.3%
(n = 33) of the sample, respectively. No significant dif-
ferences were observed in the associations between
participant background characteristics and patterns of
alcohol use, except that males were more likely to be fre-
quent drinkers and occasional drinkers than females
(Fisher’s exact test p value = 0.0019).
Table 2 shows the results of ART adherence and sexual
risk by patterns of alcohol use. First, a significant differ-
ence in self-reported days of missed ART in the past
30 days was observed between participants with different
patterns of alcohol use. Missing at least one day of ART
was more common (Fisher’s exact test p value = 0.0014)
among frequent drinkers (n = 7; 21.2%) than nondrinkers
(n = 2; 7.7%) and occasional drinkers (n = 0; 0%). The
average AGAS score was 18.0 (standard deviation
(SD) = 2.1), 17.8 (SD = 2.0), and 17.1 (SD = 2.7) for
nondrinkers, occasional drinkers, and frequent drinkers,
respectively, with no significant differences by pattern of
alcohol use (F = 1.18; p = 0.3105). For sexual risk, 49.0%
(n = 24) of occasional drinkers and 60.6% (n = 20) of
frequent drinkers reported having had sex after alcohol use,
without significant differences (Fisher’s exact test
p value = 0.4820). Approximately 23.1% (n = 6) of
nondrinkers, 34.0% (n = 17) of occasional drinkers, and
24.2% (n = 8) of frequent drinkers reported inconsistent
condom use when having sex with regular/casual/com-
mercial partners in the past 6 months, but these differences
were not statistically significant (Fisher’s exact test
p value = 0.5598).
AIDS Behav (2017) 21:S167–S173 S169
123
Table 1 Sample characteristics of people living with HIV by patterns of alcohol use (N = 109)
Characteristics Total N (%) Alcohol use, N (%) pa
Non-drinker (N = 26) Occasional drinker (N = 50) Frequent drinker (N = 33)
Age (years)
35 or young 32 (29.4) 8 (30.8) 17 (34.0) 7 (21.2) 0.0639
36–45 61 (56.0) 10 (38.4) 29 (58.0) 22 (66.7)
46 or older 16 (14.6) 8 (30.8) 4 (8.0) 4 (12.1)
Gender
Male 98 (89.9) 19 (73.1) 46 (92.0) 33 (100.0) 0.0019
Female 11 (10.1) 7 (26.9) 4 (8.0) 0 (0.0)
Education (years)
6 or less 16 (14.7) 4 (15.4) 9 (18.0) 3 (9.1) 0.7110
7–9 36 (33.0) 7 (26.9) 18 (36.0) 11 (33.3)
10 or more 57 (52.3) 15 (57.7) 23 (46.0) 19 (57.6)
Marital status
Single/divorced/widowed 30 (27.5) 7 (26.9) 12 (24.0) 11 (33.3) 0.6766
Married/living with partner 79 (72.5) 19 (73.1) 38 (76.0) 22 (66.7)
Annual family income (USD)
1000 or less 21 (19.3) 7 (26.9) 8 (16.0) 6 (18.2) 0.5893
1001–2500 55 (50.5) 14 (53.9) 24 (48.0) 17 (51.5)
2501 or more 33 (30.3) 5 (19.2) 18 (36.0) 10 (30.3)
Time of HIV diagnosis
2005 or early 26 (25.2) 5 (20.0) 10 (21.3) 11 (35.5) 0.3478
2006–2010 44 (42.7) 9 (36.0) 24 (51.1) 11 (35.5)
2011 or later 33 (32.0) 11 (44.0) 13 (27.7) 9 (29.0)
Length of ART (years)
5 or less 65 (60.2) 19 (73.1) 28 (57.1) 18 (54.6) 0.2922
6 or more 43 (39.8) 7 (26.9) 21 (42.9) 15 (45.4)
ART antiretroviral therapy
a The p value was obtained from the Fisher’s exact test
Table 2 ART adherence and sexual risk among people living with HIV by patterns of alcohol use (N = 109)
Variables Non-drinker (N = 26) Occasional drinker (N = 50) Frequent drinker (N = 33) pa
ART adherence
Self-reported missing days on ART, last 30 days, % (N)
No missing 92.3 (24) 100.0 (50) 78.8 (26) 0.0014
Missed at least one day 7.7 (2) 0.0 (0) 21.2 (7)
General adherence (AGAS), mean ± SD 18.0 ± 2.1 17.8 ± 2.0 17.1 ± 2.7 0.3105
Sexual risks
Sex after alcohol use, % (N)
No – 51.0 (25) 39.4 (13) 0.4820
Yes – 49.0 (24) 60.6 (20)
Condom use, past 6 months, % (N)
Consistent condom use/no sex 76.9 (20) 66.0 (33) 75.8 (25) 0.5598
Inconsistent condom use 23.1 (6) 34.0 (17) 24.2 (8)
AGAS Antiretroviral General Adherence Scale
a The Fisher’s exact test was used for categorical outcomes. The analysis of variance (ANOVA) test was used for continuous outcomes
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Discussion
This study found that approximately a third of the PLH
with a history of injecting drug use who were currently on
ART frequently drank alcohol (at least once a week), and
most of the drinkers were males. This finding is consistent
with previous studies conducted in Vietnam [39, 43].
Alcohol use is culturally acceptable in Southeast Asia,
where the prevalence of alcohol use disorders is the highest
in the world and males attribute much greater than females
[44]. Additionally, the prevalence of problematic alcohol
use is much higher in at-risk populations, such as drug
users and sex workers, than in the general population [45].
These factors may have contributed to the finding that
many people in Vietnam with a history of injecting drug
use continue to drink alcohol even after being diagnosed
with HIV and initiating ART [39]. Alternatively, this
finding could be explained by the theory of entitlement,
which has previously been used to understand the illicit
drug use problem in people with disabilities [40]. Similar
to how people with disabilities may feel societally “enti-
tled” to using drugs because of their disabilities, PLH with
a history of injecting drug use may be more inclined to
believe that they are entitled to use alcohol due to their
HIV status and drug use problems [46, 47]. Evidence
suggests that alcohol consumption can adversely affect
biological HIV treatment outcomes, leading to lower CD4
cell counts and higher HIV RNA viral loads [48]. Our
findings suggest that alcohol reduction interventions should
be incorporated into HIV treatment programs and should
target PLH with a history of injecting drug use.
Another important finding in this study was that frequent
alcohol drinkers appeared to have poorer ART adherence
than nondrinkers and occasional drinkers. This finding
contributes to the debate regarding whether alcohol has an
influence on HIV treatment. Previous studies have dis-
cussed possible mechanisms of how alcohol use could
negatively affect HIV treatment adherence [9, 31]. One of
the hypotheses was that PLH may choose to skip their ART
regimens after drinking alcohol for fear of an alcohol-ART
interactive toxicity [31, 32]. Another proposed explanation
was that problematic alcohol use often co-occurs with
psychiatric disorders that can subsequently impair the
ability of PLH to take their daily medications [44]. Despite
the continued problems with alcohol use among PLH
receiving ART in Vietnam, efforts to address these issues
in the past decades have been inadequate [43]. Notably,
research has shown positive effects of methadone mainte-
nance treatment (MMT) in reducing the use of both drugs
and alcohol and in improving ART adherence among PLH
[38, 40]. Thus, scaling up MMT clinics and integrating
MMT and alcohol reduction services into HIV treatment
programs could be beneficial for improving the HIV care
continuum in Vietnam.
This study found that half of the occasional drinkers and
frequent drinkers had sex after alcohol use, and at least a
third of them did not consistently use condoms. This
finding supports previous evidence which showed that a
substantial proportion of PLH consumed alcohol and
engaged in sexual risk behaviors and that PLH with a
history of injecting drug use had more unprotected sex than
other subgroups of PLH [17, 39]. Alcohol use is typically
associated with social outgoingness, and alcohol con-
sumption is commonly associated with meeting random
sexual partners and having unplanned sex [49]. A recent
study reported that compared to marijuana, alcohol use was
more likely to lead to atypical partner choices or post-sex
regret [50]. Given the potential negative effects of alcohol
on sexual behaviors, future HIV prevention and harm
reduction programs should consider patterns of alcohol use,
especially those living with HIV, to increase their aware-
ness of the sexual risks associated with alcohol use and to
guide them toward making safer sexual decisions.
Some limitations of this study should be considered
when interpreting the results. First, the data were from a
cross-sectional study, which limited our ability to draw
causal inferences between alcohol use, ART adherence,
and sexual risk. Second, as the study participants were
exclusively PLH from two provinces in Vietnam and were
mostly male, the conclusions may not be generalizable to
other groups of PLH with a history of injecting drug use,
such as female sex workers. Third, the sample size of this
study was relatively small, which might decrease the sta-
tistical power and the representativeness of the study.
Fourth, the measures used to assess alcohol use in this
study did not quantify the volume of alcohol consumption;
they only rated the frequency of use.
Conclusions
Working with PLH for safer sexual practice has become
increasingly important with the expansion of HIV treat-
ment [51]. Reducing alcohol use should be emphasized in
PLH with a history of injecting drug use during the HIV
treatment process. In addition, programs aimed at reducing
alcohol use could be integrated into current ART care for
this population. As PLH typically have regular visits with
service providers for treatment and care, routine contacts
may create greater opportunities for providers to help PLH
identify situations that could lead to sexual risks and to
address challenges related to ART and the HIV care
continuum.
AIDS Behav (2017) 21:S167–S173 S171
123
Acknowledgements The authors would like to thank the project team
members in Vietnam for their contributions to this study.
Funding This study was funded by the National Institute of Health/
National Institute on Drug Abuse (Grant Number R01DA033609)
Compliance with Ethical Standards
Conflict of interest The authors declare that they have no conflict of
interest.
Ethical Approval All procedures performed in studies involving
human participants were in accordance with the ethical standards of
the institutional and/or national research committee and with the 1964
Helsinki declaration and its later amendments or comparable ethical
standards.
References
1. Rehm J, Baliunas D, Borges GL, et al. The relation between
different dimensions of alcohol consumption and burden of dis-
ease: an overview. Addiction. 2010;105(5):817–43.
2. World Health Organization. Global status report on alcohol and
health 2014. http://www.who.int/substance_abuse/publications/
global_alcohol_report/en/. Accessed August 17, 2016.
3. Justice AC, McGinnis KA, Tate JP, et al. Risk of mortality and
physiologic injury evident with lower alcohol exposure among
HIV infected compared with uninfected men. Drug Alcohol
Depend. 2016;161:95–103.
4. Savage CL, Sanchez M. Alcohol and substance use disorder
screening, brief intervention, and referral to treatment among
people living with HIV/AIDS. J Addict Nurs. 2016;27(3):214–7.
5. Ghebremichael M, Paintsil E, Ickovics JR, et al. Longitudinal
association of alcohol use with HIV disease progression and
psychological health of women with HIV. AIDS Care. 2009;21
(7):834–41.
6. Hahn JA, Samet JH. Alcohol and HIV disease progression:
weighing the evidence. Curr HIV/AIDS Rep. 2010;7(4):226–33.
7. Kahler CW, Liu T, Cioe PA, et al. Direct and indirect effects of
heavy alcohol use on clinical outcomes in a longitudinal study of
HIV patients on ART. AIDS Behav. 2016. doi:10.1007/s10461-
016-1474-y.
8. McGinnis KA, Fiellin DA, Tate JP, et al. Number of drinks to
“feel a buzz” by HIV status and viral load in men. AIDS Behav.
2016;20(3):504–11.
9. Braithwaite RS, Bryant KJ. Influence of alcohol consumption on
adherence to and toxicity of antiretroviral therapy and survival.
Alcohol Res Health. 2010;33(3):280–7.
10. Lim JK, Tate JP, Fultz SL, et al. Relationship between alcohol
use categories and noninvasive markers of advanced hepatic
fibrosis in HIV-infected, chronic hepatitis C virus-infected, and
uninfected patients. Clin Infect Dis. 2014;58(10):1449–58.
11. Sundararajan R, Wyatt MA, Woolf-King S, et al. Qualitative
study of changes in alcohol use among HIV-infected adults
entering care and treatment for HIV/AIDS in rural southwest
Uganda. AIDS Behav. 2015;19(4):732–41.
12. Rehm J, Shield KD, Joharchi N, Shuper PA. Alcohol consump-
tion and the intention to engage in unprotected sex: systematic
review and meta-analysis of experimental studies. Addiction.
2012;107(1):51–9.
13. Shuper PA, Neuman M, Kanteres F, Baliunas D, Joharchi N,
Rehm J. Causal considerations on alcohol and HIV/AIDS-a sys-
tematic review. Alcohol Alcohol. 2010;45(2):159–66.
14. Fisher JC, Bang H, Kapiga SH. The association between HIV
infection and alcohol use: a systematic review and meta-analysis
of African studies. Sex Transm Dis. 2007;34(11):856–63.
15. Chaudhry AA, Botsko M, Weiss L, et al. Participant character-
istics and HIV risk behaviors among individuals entering
integrated buprenorphine/naloxone and HIV care. J Acquir
Immune Defic Syndr. 2011;56(Suppl 1):S14–21.
16. Crooks D, Tsui J, Anderson B, Dossabhoy S, Herman D, Lieb-
schutz JM, Stein MD. Differential risk factors for HIV drug and
sex risk-taking among non-treatment-seeking hospitalized injec-
tion drug users. AIDS Behav. 2015;19(3):405–11.
17. Scott-Sheldon LA, Walstrom P, Carey KB, Johnson BT, Carey
MP, MASH Research Team. Alcohol use and sexual risk
behaviors among individuals infected with HIV: a systematic
review and meta-analysis 2012 to early 2013. Curr HIV/AIDS
Rep. 2013;10(4):314–23.
18. Shuper PA, Joharchi N, Irving H, Rehm J. Alcohol as a correlate
of unprotected sexual behavior among people living with HIV/
AIDS: review and meta-analysis. AIDS Behav. 2009;13(6):1021–
36.
19. Stein MD, Charuvastra A, Anderson B, Sobota M, Friedmanna
PD. Alcohol and HIV risk taking among intravenous drug users.
Addict Behav. 2002;27(5):727–36.
20. Leigh BC, Morrison DM, Hoppe MJ, Beadnell B, Gillmore MR.
Retrospective assessment of the association between drinking and
condom use. J Stud Alcohol Drugs. 2008;69(5):773–6.
21. Metrik J, Caswell AJ, Magill M, Monti PM, Kahler CW. Sexual
risk behavior and heavy drinking among weekly marijuana users.
J Stud Alcohol Drugs. 2016;77(1):104–12.
22. Arasteh K, Des Jarlais DC, Perlis TE. Alcohol and HIV sexual
risk behaviors among injection drug users. Drug Alcohol Depend.
2008;95(1–2):54–61.
23. Leigh BC. Alcohol and condom use: a meta-analysis of event-
level studies. Sex Transm Dis. 2002;29(8):476–82.
24. Braithwaite RS, Conigliaro J, Roberts MS, et al. Estimating the
impact of alcohol consumption on survival for HIV+ individuals.
AIDS Care. 2007;19(4):459–66.
25. Chander G, Himelhoch S, Moore RD. Substance abuse and
psychiatric disorders in HIV-positive patients. Drugs. 2006;66
(6):769–89.
26. Cook RL, Sereika SM, Hunt SC, Woodward WC, Erlen JA,
Conigliaro J. Problem drinking and medication adherence among
persons with HIV infection. J Gen Intern Med. 2001;16(2):83–8.
27. Samet JH, Horton NJ, Meli S, Freedberg KA, Palepu A. Alcohol
consumption and antiretroviral adherence among HIV-infected
persons with alcohol problems. Alcohol Clin Exp Res. 2004;28
(4):572–7.
28. Tucker JS, Burnam MA, Sherbourne CD, Kung FY, Gifford AL.
Substance use and mental health correlates of nonadherence to
antiretroviral medications in a sample of patients with human
immunodeficiency virus infection. Am J Med. 2003;114(7):573–
80.
29. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease
inhibitor therapy and outcomes in patients with HIV infection.
Ann Intern Med. 2000;133(1):21–30.
30. Viswanathan S, Justice AC, Alexander GC, et al. Adherence and
HIV RNA suppression in the current era of highly active
antiretroviral therapy. J Acquir Immune Defic Syndr. 2015;69
(4):493–8.
31. Fatch R, Emenyonu NI, Muyindike W, Kekibiina A, Woolf-King
S, Hahn JA. Alcohol interactive toxicity beliefs and ART non-
adherence among HIV-infected current drinkers in Mbarara.
Uganda. AIDS Behav. 2016. doi:10.1007/s10461-016-1429-3.
32. Pellowski JA, Kalichman SC, Kalichman MO, Cherry C. Alco-
hol-antiretroviral therapy interactive toxicity beliefs and daily
S172 AIDS Behav (2017) 21:S167–S173
123
medication adherence and alcohol use among people living with
HIV. AIDS Care. 2016;28(8):963–70.
33. Conen A, Wang Q, Glass TR, et al. Association of alcohol con-
sumption and HIV surrogate markers in participants of the Swiss
HIV Cohort Study. J Acquir Immune Defic Syndr. 2013;64
(5):472–8.
34. Kowalski S, Colantuoni E, Lau B, et al. Alcohol consumption and
CD4 T-cell count response among persons initiating antiretroviral
therapy. J Acquir Immune Defic Syndr. 2012;61(4):455–61.
35. Wandeler G, Kraus D, Fehr J, et al. The J-Curve in HIV: low and
moderate alcohol intake predicts mortality but not the occurrence
of major cardiovascular events. J Acquir Immune Defic Syndr.
2016;71(3):302–9.
36. National Committee for AIDS, Drugs and Prostitution Prevention




37. World Health Organization. Global status report on alcohol and
health 2011. http://www.who.int/substance_abuse/publications/
global_alcohol_report/msbgsruprofiles.pdf. Accessed 19 Sept
2016.
38. Tran BX, Ohinmaa A, Duong AT, et al. Changes in drug use are
associated with health-related quality of life improvements
among methadone maintenance patients with HIV/AIDS. Qual
Life Res. 2012;21(4):613–23.
39. Tran BX, Nguyen LT, Do CD, Nguyen QL, Maher RM. Asso-
ciations between alcohol use disorders and adherence to
antiretroviral treatment and quality of life amongst people living
with HIV/AIDS. BMC Public Health. 2014;14:27.
40. Palepu A, Horton NJ, Tibbetts N, Meli S, Samet JH. Uptake and
adherence to highly active antiretroviral therapy among HIV-
infected people with alcohol and other substance use problems:
the impact of substance abuse treatment. Addiction. 2004;99
(3):361–8.
41. World Health Organization. Good practice in Asia: targeted HIV
prevention for injecting drug users and sex workers. www.who.
int/hiv/pub/idu/good_practice_aisa_idu.pdf. Accessed 17 Aug
2016.
42. Holstad MM, Foster V, Diiorio C, McCarty F, Teplinskiy I. An
examination of the psychometric properties of the Antiretroviral
General Adherence Scale (AGAS) in two samples of HIV-in-
fected individuals. J Assoc Nurses AIDS Care. 2010;21(2):162–
72.
43. Tran BX, Nguyen N, Ohinmaa A, et al. Prevalence and correlates
of alcohol use disorders during antiretroviral treatment in injec-
tion-driven HIV epidemics in Vietnam. Drug Alcohol Depend.
2013;127(1–3):39–44.
44. Rehm J, Mathers C, Popova S, Thavorncharoensap M, Teer-
awattananon Y, Patra J. Global burden of disease and injury and
economic cost attributable to alcohol use and alcohol-use disor-
ders. Lancet. 2009;373(9682):2223–33.
45. Fritz K, Morojele N, Kalichman S. Alcohol: the forgotten drug in
HIV/AIDS. Lancet. 2010;376(9739):398–400.
46. Moore, D. Substance abuse and persons with disabilities: a sig-
nificant public health problem. American Public Health
Association Conference, Atlanta. 1991.
47. Moore D, Li L. Prevalence and risk factors of illicit drug use by
people with disabilities. Am J Addict. 1998;7(2):93–102.
48. Azar MM, Springer SA, Meyer JP. Altice FL.A systematic
review of the impact of alcohol use disorders on HIV treatment
outcomes, adherence to antiretroviral therapy and health care
utilization. Drug Alcohol Depend. 2010;112(3):178–93.
49. Townshend JM, Kambouropoulos N, Griffin A, Hunt FJ, Milani
RM. Binge drinking, reflection impulsivity, and unplanned sexual
behavior: impaired decision-making in young social drinkers.
Alcohol Clin Exp Res. 2014;38(4):1143–50.
50. Palamar JJ, Acosta P, Ompad DC, Friedman SR. A qualitative
investigation comparing psychosocial and physical sexual expe-
riences related to alcohol and marijuana use among adults. Arch
Sex Behav. 2016. doi:10.1007/s10508-016-0782-7.
51. Kalichman SC. Positive prevention: reducing HIV transmission
among people living with HIV/AIDS. New York: Springer; 2005.
AIDS Behav (2017) 21:S167–S173 S173
123
